# Lakefront Biotherapeutics (LKFT)

Source: https://www.quantisnow.com/company/LKFT
Generated: 2026-11-17T02:02:14.708Z

- Ticker: LKFT
- Exchange: NASDAQ
- Sector: Health Care
- Industry: Biotechnology: Pharmaceutical Preparations
- IPO year: 2015
- SEC CIK: 0001421876
- Website: https://www.glpg.com

## About

Lakefront Biotherapeutics is a biotechnology company dedicated to building a differentiated pipeline of medicines for patients with serious diseases in areas of high unmet need. The Company has established a clinical-stage portfolio in immunology and inflammation, anchored by gamgertamig, a potential first-in-class and best-in-class BCMAxCD3 T-cell engager for autoimmune diseases. Backed by deep deal-making expertise, operational flexibility, and a strong capital position, Lakefront identifies, acquires, and advances high-quality assets with clear potential to deliver meaningful patient impact and long-term shareholder value.

## Latest LKFT news and filings

- 2026-11-16 14:58 UTC [SEC Form 6-K] [SEC Form 6-K filed by Lakefront Biotherapeutics](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakefront-biotherapeutics-6792944)
- 2026-11-16 06:30 UTC [Mergers & Acquisitions] [Lakefront Initiates New €50 Million Share Repurchase Program Following Completion of Initial Share Repurchase Program](https://www.quantisnow.com/insight/lakefront-initiates-new-50-million-share-repurchase-program-following-completion-6791861)
- 2026-11-12 11:15 UTC [SEC Form 6-K] [SEC Form 6-K filed by Lakefront Biotherapeutics](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakefront-biotherapeutics-6785818)
- 2026-11-11 01:32 UTC [SEC Form 6-K] [SEC Form 6-K filed by Lakefront Biotherapeutics](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakefront-biotherapeutics-6785634)
- 2026-11-11 21:01 UTC [Mergers & Acquisitions] [Lakefront Biotherapeutics Reports Nine Months 2026 Financial Results and Provides Business Update](https://www.quantisnow.com/insight/lakefront-biotherapeutics-reports-nine-months-2026-financial-results-and-provides-6785435)
- 2026-11-10 21:01 UTC [Conference Announcement] [Lakefront to Present at the 2026 Jefferies Global Healthcare Conference in London](https://www.quantisnow.com/insight/lakefront-to-present-at-the-2026-jefferies-global-healthcare-conference-6783735)
- 2026-11-04 14:52 UTC [SEC Form 6-K] [SEC Form 6-K filed by Lakefront Biotherapeutics](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakefront-biotherapeutics-6771783)
- 2026-11-04 14:01 UTC [Earnings Date] [Lakefront Biotherapeutics Announces Poster Presentation at the 2026 American Society of Hematology Meeting](https://www.quantisnow.com/insight/lakefront-biotherapeutics-announces-poster-presentation-at-the-2026-american-society-6771693)
- 2026-11-02 21:35 UTC [SEC Form 6-K] [SEC Form 6-K filed by Lakefront Biotherapeutics](https://www.quantisnow.com/insight/sec-form-6-k-filed-by-lakefront-biotherapeutics-6767550)
- 2026-11-02 21:01 UTC [Leadership Update] [Lakefront Biotherapeutics Welcomes Dr. Mehdi Shahidi to its Board of Directors](https://www.quantisnow.com/insight/lakefront-biotherapeutics-welcomes-dr-mehdi-shahidi-to-its-board-of-6766922)

## More

- Live page with ratings, short volume, options and peers: https://www.quantisnow.com/company/LKFT
- Earnings history: https://www.quantisnow.com/earnings/LKFT
- Dividend history: https://www.quantisnow.com/dividends/LKFT
- Insider transactions: https://www.quantisnow.com/insiders/LKFT
- Options chain: https://www.quantisnow.com/options/LKFT
- SEC 8-K filings only: https://www.quantisnow.com/company/LKFT/8-k
- RSS and alerts for LKFT: https://www.quantisnow.com/docs/rss-feeds.md
